Alyeska Investment Group’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.92M Buy
2025
Q2
$5.06M Hold
2025
Q1
$3.65M Sell
2024
Q4
$13.2M Buy
2024
Q3
$1.81M Buy
2021
Q2
Sell
2021
Q1
$1.09M Hold
2020
Q4
$1.16M Buy